Taking Dulcolax with Wegovy: what you should know

Why constipation happens on Wegovy, and how often

The STEP 1 trial, published in the New England Journal of Medicine, enrolled over 1,900 adults with obesity and tracked the side-effect profile of semaglutide 2.4mg over 68 weeks. Gastrointestinal symptoms were the most commonly reported adverse events throughout: nausea, diarrhoea and constipation all featured prominently. Constipation was notably more common in the semaglutide group than in those taking placebo, and it tended to cluster around dose increases rather than settling in as a constant problem.

The mechanism is straightforward. Semaglutide activates GLP-1 receptors in the gut wall, slowing the rate at which the stomach empties into the small intestine. Less movement through the system means the colon absorbs more water from stool, making it harder and more difficult to pass. This is not a sign that something has gone wrong, it is a known and expected pharmacological effect. Understanding this can help you manage it more confidently alongside your treatment, rather than worrying that something is wrong.

For most people the constipation is mild and improves within a few days to two weeks, particularly as the body adjusts to a new dose. Adequate hydration, dietary fibre and gentle movement all play a supporting role; the NHS patient information page for semaglutide covers this in plain language and is worth reading alongside your Patient Information Leaflet.

Where Dulcolax fits, and what 'no interaction' actually means

Bisacodyl, the active ingredient in Dulcolax, acts locally in the colon. It irritates the bowel lining to stimulate muscle contractions, pushing stool along. Because it is minimally absorbed into systemic circulation, it does not rely on the same pathways that semaglutide affects, and no pharmacokinetic interaction between the two is documented in UK prescribing references or the semaglutide interaction list.

That is genuinely reassuring, but it is not quite the full picture. Wegovy's effect on gastric emptying means oral medicines can take longer to reach their site of action. For a drug like bisacodyl, which needs to reach the colon to work, a slower transit time through the upper gut might simply mean it takes a little longer to act than the packaging suggests. This is unlikely to cause harm, but it is a practical thing to be aware of.

Occasional use of a stimulant laxative to manage a short-term flare of constipation around a dose increase is a different situation from taking one regularly over weeks or months. Long-term stimulant laxative use can affect bowel function in its own right, and if constipation is persistent your prescriber may prefer to explore other approaches (osmotic laxatives, increased fibre, or adjusting your Wegovy titration schedule) before routine stimulant use becomes a habit. Our page on getting the most from Wegovy has practical guidance on managing side effects day to day.

Other laxatives, and the medicines to be more careful about

Bisacodyl is not the only option. Osmotic laxatives such as lactulose or macrogol (Movicol) draw water into the bowel and are often recommended first for semaglutide-related constipation because they work without stimulating the bowel muscle. Bulk-forming laxatives like Fybogel can also help, provided you drink enough fluid alongside them. Any of these should still be discussed with your prescriber if you find yourself relying on them regularly.

The interaction picture becomes more complex with oral medicines that have narrow therapeutic windows or that depend on precise absorption timing. If you are also taking oral contraceptives, the full guide to medicines to be careful about with semaglutide explains why the absorption timing question matters more for some drugs than others. Statins are another commonly asked-about class; the position on those is covered separately on our page about Wegovy and statins.

It is also worth keeping in mind that severe or prolonged vomiting or diarrhoea (less common but possible) can cause dehydration that places strain on the kidneys. If a gastrointestinal episode is lasting more than a couple of days or stopping you from keeping fluids down, that is a reason to contact a healthcare professional rather than manage it with over-the-counter remedies alone. The MHRA encourages patients to report any unexpected side effects via the Yellow Card scheme, which helps build the evidence base on real-world medicine use.

Getting the right support from your prescriber

If you started Wegovy through a private route and you are unsure who to ask about a specific side effect or an over-the-counter remedy, that aftercare gap is worth thinking about. The detailed guide on Dulcolax and Wegovy covers this topic at greater length. Some providers offer access to a prescriber around dose increases (which is when bowel symptoms are most likely to crop up) and others do not.

At nume, aftercare is available seven days a week. If constipation is bothering you around a new dose or a bank holiday week when your usual routines have shifted, you can reach our clinical team without waiting for the next appointment slot. That kind of access matters most when symptoms appear at inconvenient moments, a Monday after a long weekend, say, or the week a new pen arrives just before payday meant it sat in the fridge a little longer than planned.

If you have not yet started treatment and you are weighing up how Wegovy works in practice, including what side effects to expect and how they tend to be managed, speaking to our prescribers is a natural first step. Clinical assessment is where the right conversation begins.